Euro slides to 2-month low as yearly support test looms

source:

[1] Euro Short-term Outlook: EUR/USD Selloff Nears Critical Yearly Support (https://www.forex.com/en-us/news-and-analysis ...)[2] One place for your portfolios, metrics and more (https://finance.yahoo.com/portfolios/ ...)[3] Politics latest: UK to review Chagos deal after Trump criticism (https://news.sky.com/story/politics-latest-bu ...)[4] San Diego Union-Tribune (https://www.sandiegouniontribune.com/ ...)[5] United States (https://www.aljazeera.com/where/united-states ...)

Related News

Sep 23 2026, 19:27

Rosen probes Anavex over disclosures tied to CEO's for-cause exit

Rosen Law Firm said it is investigating potential securities claims against Anavex Life Sciences Corp. (NASDAQ: AVXL) over allegations the company issued materially misleading business information, four months after the biotech's board fired its chief executive for cause. The New York-based plaintiffs' firm, which says it has recovered billions of dollars for investors and was ranked No. 1 by ISS Securities Class Action Services for the number of securities class action settlements in 2017, is preparing a class action and is soliciting shareholders who bought Anavex securities. "If you purchased Anavex securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement," the firm said in its Sept. 21 notice, which directs investors to contact Phillip Kim, Esq. at 866-767-3653. The investigation traces to a Form 8-K Anavex filed with the SEC on May 6, 2026. In that filing, a special committee of the board said it had "terminated the employment of Christopher Missling, PhD as the Company's Chief Executive Officer for Cause," effective immediately, "for, among other things, conduct that the Special Committee believed was inconsistent with Company policy." The committee also asked Missling to resign from the board. Anavex has not disclosed the specific conduct at issue, and the company did not immediately respond to a request for comment on the Rosen notice. Rosen's notice does not name a class period, a proposed lead plaintiff, or a damages figure, and no complaint has been filed. Under the Private Securities Litigation Reform Act, a lead-plaintiff motion is typically due within 60 days of the first published notice — a window that, measured from the Sept. 21 announcement, would close in late November 2026. The firm's economics are contingency-based: shareholders pay no upfront fees, and counsel recovers a percentage of any settlement or judgment, typically 20% to 33% of the recovery after court approval. The disclosure gap is the crux. A for-cause termination tied to conduct "inconsistent with Company policy" raises the question of what the board knew and when it knew it, and whether earlier statements about Missling's leadership or Anavex's clinical programs were accurate when made. Anavex's lead asset, blarcamesine (Anavex 2-73), is an oral sigma-1 receptor agonist in development for Alzheimer's disease and Parkinson's disease; the company has reported Phase 2b/3 data in Alzheimer's and is pursuing regulatory pathways in multiple jurisdictions. Any litigation that forces disclosure of internal communications around those programs carries reputational weight beyond the legal cost. For holders, the near-term risk is a two-track overhang: legal expense and management distraction on one side, and the unresolved question of why the board acted on the other. Anavex has not disclosed a successor CEO, a restated financial, or an amended 8-K expanding on the special committee's findings. Those three items — plus any lead-plaintiff filing in federal court — are the events that will determine whether this stays a law-firm notice or becomes a docketed case with a defined damages claim. Peer context matters for scale. Securities class actions against small- and mid-cap biotechs are common after abrupt executive departures, and most settle rather than reach trial; the median settlement in such cases runs in the low single-digit millions of dollars, a fraction of the headline losses alleged. That math matters for a company of Anavex's size, where defense costs alone can consume a meaningful share of cash reserves before any settlement is reached. The stock's reaction to the Rosen announcement was not disclosed in the firm's notice, and Anavex has not commented on the investigation. Investors will watch for an amended 8-K or a formal complaint, either of which would convert an open inquiry into a dated legal proceeding. This article is for informational purposes only and does not constitute investment advice.

Sep 23 2026, 19:11

Silver falls 4% to $64.47 as UBS holds $80 target

Spot silver slid 4% to $64.47 an ounce on Sept. 23, 2026, its steepest one-day decline of the current advance, even as UBS held a price target roughly 24% above that level. The Swiss bank's $80/oz call rests on two demand pillars it says operate independently of the daily tape: investors buying the metal as a hedge against fiscal deterioration, and industrial spending on electrification. UBS strategists Wayne Gordon and Dominic Schnider set the path on Aug. 29, 2026 and reaffirmed it twice in September, according to the bank's published outlook. The full trajectory runs $70/oz by December 2026, $75/oz by March 2027, $75/oz by June 2027 and $80/oz by September 2027. Those figures sit well below where UBS stood earlier in 2026, when it carried $95/oz to $100/oz targets. In May 2026 the bank cut its 2026 silver supply-deficit estimate by about 80%, from roughly 300 million ounces to 60-70 million ounces, removing the physical-scarcity pillar that had justified the higher numbers. That revision history matters for how the current target should be read. The $80/oz September 2027 figure is a moderated bull case leaning on monetary debasement and resilient industrial offtake, not on a tight physical market. UBS itself flags four conditions that "could interrupt the advance": industrial substitution away from silver at elevated prices, weaker global growth suppressing solar and electronics demand, a more hawkish Federal Reserve, and an unwind of crowded long futures positions. Silver's dual identity explains the volatility. UBS describes the metal as a high-beta equivalent of gold — it moves in the same direction but with larger percentage swings, because it carries both a monetary store-of-value role and heavy industrial demand in solar panels, electronics and automotive applications. Gold does not carry the industrial half. In the 2010-2011 bull run silver approached $50/oz and outperformed gold on a percentage basis; in 2013-2015, as industrial demand softened after quantitative easing ended, it fell far harder than gold on the way down. ## Gold correlation is the swing factor The fiscal-hedge leg of the thesis is a gold trade by proxy. If gold grinds higher on U.S. deficit and dollar-purchasing-power concerns, silver's high-beta character means it should outpace gold in percentage terms. If the Fed delivers more tightening than priced, or Chinese manufacturing activity weakens, the drawdown should exceed gold's. That asymmetry is the practical sizing question for anyone weighing silver exposure against a gold position. The industrial leg is where electrification enters. Silver's demand runs through solar panels, electronics and automotive applications, making it sensitive to manufacturing cycles in a way a pure safe-haven asset is not. UBS's targets assume a relatively benign industrial demand environment — an assumption that weakening Chinese factory data would directly challenge. For scale, the $64.47 print leaves silver about 24% below the $80/oz target and roughly 4% below the $70/oz December 2026 level. The metal traded in the mid-$60s through late September, having recovered from an intraday $62.57/oz after the Fed's Sept. 16 rate decision, according to Reuters. That recovery speed is itself a data point: a market treating the hike as structurally bearish would not have clawed the ground back within days. Three variables decide whether the path holds. The Fed's trajectory beyond October is the most direct threat to the dollar-sensitive side of the thesis. Industrial demand signals across solar, electronics and Chinese manufacturing test the second pillar. Dollar strength remains the primary macro headwind for all precious metals and pressures silver's monetary appeal directly. This article is for informational purposes only and does not constitute investment advice.

Sep 23 2026, 18:40

WTI crude jumps 1.8% to $92.16 as Murban premium hits $19

A $19.30 gap has opened between the Middle East and U.S. crude benchmarks, after Abu Dhabi's Murban grade outran West Texas Intermediate by roughly 76 basis points in a single session and left traders asking whether Gulf barrels are genuinely short or merely expensive to ship. WTI for November delivery settled up $1.64, or 1.81 percent, at $92.16 a barrel on Sept. 22. Murban climbed 2.57 percent to $111.46 over the same session, a premium that points to tightening non-Atlantic supply rather than a uniform bid across the barrel. "The Murban-WTI gap is doing the talking here," said Omar Tafesh, head of crude research at Gulf Commodities Analytics in Dubai. "When the Middle East marker outruns the U.S. benchmark by this margin, the market is pricing freight, insurance and a geopolitical risk premium into every cargo leaving the Gulf, not simply stronger global demand." The move was broad across the energy complex. NYMEX October gasoline settled at $3.5870 a gallon and October heating oil at $4.7764 a gallon, both firm enough to suggest refiners are passing through higher feedstock costs rather than absorbing them. NYMEX October natural gas closed at $3.0230 per million British thermal units, a separate input anchor that has not tracked the crude rally step for step. The spread is the story. A $19.30 premium for a Gulf sour grade over a U.S. light sweet benchmark is wide by recent standards and implies that barrels east of Suez are being valued for their proximity to Asian demand centers, not for their quality differential alone. A divergence of this size would be unusual if the driver were a simple risk-on move in commodities. That divergence matters for anyone holding energy exposure. Integrated majors with Gulf-linked upstream portfolios capture the higher realizations on Middle East barrels, while U.S. shale producers selling into the WTI benchmark see a narrower uplift. Refiners face the opposite arithmetic: a widening light-heavy and regional spread compresses the crack they earn on a barrel of crude, even as product prices rise. The last time the Murban-WTI spread pushed toward this territory, Asian refiners responded by trimming spot purchases of Gulf grades within weeks and leaning on Atlantic-basin cargoes, a substitution that eventually pulled the premium back toward its historical band. Whether that mechanism engages again depends on how much of the current premium is freight and insurance versus genuine supply scarcity. For the broader market, the read-through runs through inflation expectations. Crude at $92.16 with products at $3.5870 a gallon for gasoline feeds directly into headline consumer price prints, and energy equities typically lead the tape higher on settlement days like this one. Rate-sensitive sectors — utilities, real estate, long-duration growth — carry the offsetting burden, because a sustained energy bid complicates any path toward easier monetary policy. The next test comes with the weekly U.S. inventory data and the following OPEC production survey, both of which will show whether the Gulf premium reflects barrels that are genuinely short or simply expensive to move. If Murban holds above $110 while WTI stalls near $92, the spread is telling traders something about supply geography that a single benchmark cannot. If the gap narrows, the Sept. 22 rally was a one-day repricing and not a regime change. This article is for informational purposes only and does not constitute investment advice.